These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2502083

  • 1. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV, Tsyganenko AIa.
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [Abstract] [Full Text] [Related]

  • 2. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
    Minukhin VV, Tsyganenko VIa.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF, Kharitonova AM, Chanturiia TsK.
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination].
    Minukhin VV, Tsyganenko AIa.
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D, Serafińska D, Rudowski W, Hoffman S, Olański W, Gardzińska E, Popiel D, Jedrzejczak G, Czarnecka I.
    Pol Tyg Lek; 1986 Oct; 44(43-45):924-7. PubMed ID: 2518666
    [Abstract] [Full Text] [Related]

  • 9. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, Mahdavi M.
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [Abstract] [Full Text] [Related]

  • 10. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
    Orłowski T, Struzyna J, Badowski A, Schiller B, Kuntze A, Kozaczek W, Goller W.
    Wiad Lek; 1980 Nov 01; 33(21):1697-701. PubMed ID: 6784349
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A, Meitert E, Vasiliu S, Meitert T, Milicescu S, Sima F, Savulian C.
    Arch Roum Pathol Exp Microbiol; 1979 Nov 01; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract] [Full Text] [Related]

  • 14. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations.
    Holder IA, Naglich JG.
    J Trauma; 1986 Feb 01; 26(2):118-22. PubMed ID: 2418208
    [Abstract] [Full Text] [Related]

  • 15. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL, Purdue GF.
    J Trauma; 1988 Feb 01; 28(2):146-51. PubMed ID: 3126302
    [Abstract] [Full Text] [Related]

  • 16. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M, Behrouz B, Irajian G, Mahdavi M, Korpi F, Motamedifar M.
    Microb Pathog; 2016 Dec 01; 101():83-88. PubMed ID: 27836762
    [Abstract] [Full Text] [Related]

  • 17. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE, Small GJ.
    J Infect Dis; 1987 May 01; 155(5):973-8. PubMed ID: 3104484
    [Abstract] [Full Text] [Related]

  • 18. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
    Schiller B, Buchowicz I, Lysakowska E, Sakiel S, Korbecki M.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr 01; (4):30-2. PubMed ID: 2409720
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas immunoglobulin and vaccine in burn patients.
    Bose B.
    Lancet; 1981 Feb 21; 1(8217):435. PubMed ID: 6110056
    [No Abstract] [Full Text] [Related]

  • 20. [Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia].
    Vetkova LG, Zaĭtsev LG, Khasman EL, Radkevich SA, Moroz AF.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar 21; (3):14-8. PubMed ID: 3085409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.